About Exothera
Exothera is a Healthcare company based in Brussels (Belgium) founded in 2020 by Jose Castillo. Clinical trial services to biopharma sector are provided by CDMO. Exothera offers products and services including Viral Based Services, RNA Services, and Analytical Services. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Cell and Gene Therapy. Its legal entity is Exothera SA. Its competitors include MaSTherCell and Genflow Biosciences; 1 of its 2 listed competitors has raised funding.
Company details
Exothera was established in 2020 and is based in Brussels, Belgium. Operations are conducted as a contract development and manufacturing organization (CDMO) within the biopharma industry. Clinical trial services are delivered to support biopharmaceutical clients in development and manufacturing processes. Leadership is provided by co-founder Jose Castillo, with focus maintained on sector-specific needs in Europe.
- Headquarters Brussels, Belgium
- Founders Jose Castillo
- SectorsHealthcare
- Website exothera.world
- Social LinkedIn X YouTube
- Legal Name Exothera Sa
- Latest Funding Round$402.13K (USD), Grant
Oct 2022
- Investors
Products & Services of Exothera
Exothera offers a comprehensive portfolio of products and services, including Viral Based Services, RNA Services, and Analytical Services.
Offers production and development for viral vectors and vaccines.
Provides continuous-batch RNA manufacturing for therapeutics.
Delivers method development and validation for quality assurance.
Apps and channels of Exothera
its YouTube channel Exothera has 23 subscribers and 8 videos.
Videos from Exothera
The most watched videos on Exothera's YouTube channel, Exothera (23 subscribers). Click a video to play it here.
More on Exothera.
Funding Insights of Exothera
- Total Rounds 1
- Last Round Grant — $402,126
- First Round $402,126
(Oct 2022)
- Investors Count 1
All 1 funding rounds of Exothera with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2022 | $402,126 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Exothera
Exothera has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Exothera
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Exothera
13 people are tracked at Exothera (5 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Jose Castillo | Co-Founder | Leadership |
Vincent Dubois | Head Of Quality (qa/qc), Qualified Person | Leadership |
Koen Coorevits | Head Of Technical Service | Leadership |
Sylvia Haller | Marketing Director | Leadership |
Benjamin Depierreux | Head Of E2e Solutions | Leadership |
Céline Delecourt | DSP Bioprocess Engineer | Team |
Lander Monné | Strategy Manager | Team |
Vladimir Ivošev | Commercial Manager | Team |
Nicolas Delrée | Supply Chain Planning | Team |
Fabien Baldacci-Cresp | Manager Analytical Science Team | Team |
Solène Arnoult | Senior USP Scientist - Process Development And GMP | Team |
Thomas le Gall | Project Manager | Team |
Dmitry Sorokin | CMC And Regulatory Manager | Team |
Complete people profiles for Exothera
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Exothera
2 dated milestones of Exothera across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Exothera is founded.
- Funding First funding round of $402K.
Competitors of Exothera
Exothera has 2 listed competitors in our database, 1 of them funded. They include MaSTherCell and Genflow Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| masthercell.com | 2011 | Charleroi, Belgium | $17.37M | 329 | Services for cell therapy development and manufacturing are provided. | |
| genflowbio.com | 2020 | Charleroi, Belgium | 5 | A biotechnology company focused on anti-aging therapeutics development. |
Detailed competitors of Exothera
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Exothera
Complete news archive for Exothera
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Exothera
Exothera was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Exothera is headquartered in Brussels, Belgium. It is registered at Brussels, Brussels-capital Region, Belgium.
Exothera was established in 2020 and is based in Brussels, Belgium. Operations are conducted as a contract development and manufacturing organization (CDMO) within the biopharma industry. Clinical trial services are delivered to support biopharmaceutical clients in development and manufacturing processes. Leadership is provided by co-founder Jose Castillo, with focus maintained on sector-specific needs in Europe.
Exothera's top competitors include MaSTherCell and Genflow Biosciences.
Exothera offers Viral Based Services, RNA Services, and Analytical Services.
Exothera has 1 investor. Key investors include European Union.
Exothera operates through Exothera Sa.